Chemotherapy-induced immunosuppression and reconstitution of immune function

Leukemia Research

Volumn 26, Issue 4, 2002, Pages 411-414

  Steele, Timothy A ^a  

^a DES MOINES UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; ANTIINFECTIVE AGENT; CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CLADRIBINE; COLONY STIMULATING FACTOR; CYTOKINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 7; MITOGENIC AGENT; T LYMPHOCYTE RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANAPHYLAXIS; ANTIBODY TITER; B LYMPHOCYTE; BACTERIAL INFECTION; BLOOD CELL COUNT; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CELL ACTIVITY; CHRONIC LYMPHATIC LEUKEMIA; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DYSPEPSIA; HEMATOPOIETIC CELL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NAUSEA; NEUTROPENIA; NONHUMAN; NOTE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SURVIVAL RATE; T LYMPHOCYTE; THORAX PAIN; THYMUS ATROPHY; VIRUS INFECTION;

ANTINEOPLASTIC AGENTS; HUMANS; IMMUNE TOLERANCE; NEOPLASMS;

EID: 0036168728     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00138-2     Document Type: Note

References (33)

1. Enhancement of leukemia rejection by mice successfully treated for L1210 leukemia due to low dose compared to high dose VP-16
2. Chronic lymphocytic leukemia and its impact on the immune system
3. T-cell immunodeficiency following cytotoxic antineoplastic therapy: A review
4. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia
5. Immune reconstitution after autologous purged bone marrow transplantation in children
6. Reconstitution of peripheral blood lymphocyte subsets in the long-term disease-free survivors of patients with acute myeloblastic leukemia
7. T-cells and natural killer cells after treatment of hairy cell leukemia with 2-chlorodeoxyadenosine
8. Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukemia and solid tumors
9. Host defense, viruses and apoptosis
10. Natural killer cells and tumor therapy
11. Natural killer cells and cancer
12. Immune recovery in children with malignancy after cessation of chemotherapy
13. + T-lymphocytopenia in long-term survivors following intensive chemotherapy in childhood cancers
14. Attempted reconstruction of the immune system using low doses of interleukin-2 in chronic lymphocytic leukemia patients treated with 2-chlorodeoxyadenosine: Results of a pilot study
15. + T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy
16. T-cell regeneration: All repertoires are not created equal
17. Thymic involution in aging
18. Cytokine responsiveness of mitogen-activated T-cells derived from acute leukemia patients with chemotherapy-induced leukopenia
19. Cellular immune responses in acute leukemia patients with severe chemotherapy-induced leucopenia characterization of the cytokine repertoire of clonogenic T-cells
20. Different interleukin-1 beta converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli
21. Constraints on CD4 recovery post-chemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells
22. Update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines
23. Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem-cell transplantation
24. Interleukin-3 in hematology and oncology: Current state of knowledge and future directions
25. Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: Expansion of immune effectors within the stem-cell graft and post-stem-cell infusion
26. A potential role for interleukin-7 in T-cell homeostasis
27. Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults
28. Antileukemic effect of chronic graft versus host disease: Contribution to improved survival after allogeneic marrow transplantation
29. New approaches to treating malignances with stem-cell transplantation
30. Adoptive allogeneic immunotherapy - History and future perspectives
31. The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse
32. Graft versus leukemia effect of donor lymphocyte transfusions in marrow grafted patients
33. Donor leukocyte transfusions for leukemic relapse